{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:50Z","timestamp":1791356330607,"version":"4.3.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.04.048","type":"journal-article","created":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T09:33:55Z","timestamp":1178616835000},"page":"A92-A96","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S1","title":["Effectiveness of a trivalent serogroup A\/C\/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003"],"prefix":"10.1016","volume":"25","author":[{"given":"Montse","family":"Soriano-Gabarr\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"To\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvestre R.M.","family":"Tiendrebeogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumouni","family":"Dabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoudou H.","family":"Djingarey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Plikaytis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.04.048_bib1","first-page":"67","article-title":"Meningococcal disease and season in sub-Saharan Africa","volume":"123","author":"Greenwood","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.04.048_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"37","key":"10.1016\/j.vaccine.2007.04.048_bib3","first-page":"313","article-title":"Enhanced surveillance of epidemic meningococcal meningitis in Africa: a 3-year experience","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"38","key":"10.1016\/j.vaccine.2007.04.048_bib4","first-page":"306","article-title":"Detecting meningococcal meningitis epidemics in highly endemic African countries. WHO recommendation","volume":"75","year":"2000","journal-title":"Wkly Epidemiol Rec"},{"issue":"18","key":"10.1016\/j.vaccine.2007.04.048_bib5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2007.04.048_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3201\/eid0906.020565","article-title":"Serogroup W-135 meningococcal disease during the Hajj, 2000","volume":"9","author":"Lingappa","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.048_bib7","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/340414","article-title":"Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex","volume":"185","author":"Mayer","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.048_bib8","unstructured":"World Health Organization. Meningococcal disease, serogroup W-135, Burkina Faso. Preliminary Report, 2002. Wkly Epidemiol Rec 2002; 18:152\u20135."},{"key":"10.1016\/j.vaccine.2007.04.048_bib9","unstructured":"World Health Organization. The use of polysaccharide trivalent ACW vaccine for the control of epidemic meningococcal disease outbreaks in countries of the African meningitis belt. Recommendations from an international informal consultation. World Health Organization, Geneva 2003, WHO\/CDS\/CSR\/GAR\/2003.14."},{"key":"10.1016\/j.vaccine.2007.04.048_bib10","unstructured":"Tiendrebeogo SR, Soriano-Gabarro M, Djingarey MH, Traore E, Jones J, Croisier A, et al. In: Abstracts of the 14th international pathogenic Neisseria conference, 2004. Milwaukee, WI, Milwaukee. Organizing committee of the 14th international pathogenic Neisseria conference, 2004: 41."},{"key":"10.1016\/j.vaccine.2007.04.048_bib11","unstructured":"World Health Organization. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO\/CDS\/CSR\/EDC\/99\/7\/EN 1999."},{"key":"10.1016\/j.vaccine.2007.04.048_bib12","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. The analysis of case\u2013control studies, vol. 1. Classical methods of analysis of matched data (IARC Scientific Publication no. 32). Lyon, France: International Agency for Research on Cancer; 1980 [chapter 5]."},{"key":"10.1016\/j.vaccine.2007.04.048_bib13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children 3 months to 5 years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2007.04.048_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide vaccine","volume":"2","author":"Reingold","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.04.048_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0035-9203(86)90303-2","article-title":"The efficacy of meningococcal polysaccharide vaccines in preventing group A meningococcal disease in The Gambia, West Africa","volume":"80","author":"Greenwood","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.04.048_bib16","unstructured":"World Health Organization. Surveillance integr\u00e9e des maladies prioritaires et riposte dans le bloc de l\u2019Afrique de l\u2019Ouest. Bulletin d\u2019information et de retro-information N 12. WHO. ICST\/CSR\/WAB, 2006."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T15:20:59Z","timestamp":1546874459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":16,"alternative-id":["S0264410X07004732"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}